These discoveries in mouse hepatocytes and C. elegans confirmed that overexpression of RTN3 can disrupt the morphology and function of mitochondria, which may further affect lipid catabolism in hepatocytes and result in NAFLD. Here, RTN3 is linked to metabolic dysfunction-associated steatotic liver disease.